| 17β-HSD1 | 17β-hydroxysteroid dehydrogenases type 1 |
| 17β-HSD2 | 17β-hydroxysteroid dehydrogenases type 2 |
| AR | Androgen receptor |
| ATM | Ataxia telangiectasia mutated |
| ATR | Ataxia telangiectasia and Rad3 related |
| BP | Butylparaben |
| BMI | Body mass index |
| BzP | Benzylparaben |
| CCND1 | Cyclin D1 |
| CCND3 | Cyclin D3 |
| CCNE1 | Cyclin E1 |
| CCNE2 | Cyclin E2 |
| CCNA2 | Cyclin A2 |
| CDK2 | Cyclin Dependent Kinase 2 |
| CDK4 | Cyclin Dependent Kinase 4 |
| CDK6 | Cyclin Dependent Kinase 6 |
| CDKN1A | Cyclin Dependent Kinase Inhibitor 1A |
| CYP19A1 | cytochrome P450 19A1 (aromatase) |
| DHT | Dihydrotestosterone |
| E2F3 | Transcription factor E2F3 |
| EEF | Estradiol equivalence factor |
| E1 | Estrone |
| E2 | 17β-estradiol |
| ER | Estrogen receptor |
| EDCs | Endocrine-disruptive chemicals |
| EMT | Epithelial-to-mesenchymal transitions |
| EP | Ethylparaben |
| GPER | G-protein-coupled estrogen receptor (GPR30 or GPER1) |
| GR | Glucocorticoid receptor |
| HeP | hexylparaben |
| HepP | Heptylparaben |
| HER2 | Human epidermal growth factor receptor 2 |
| HRG | Heregulin |
| IsoBP | Isobutylparaben |
| IsoPP | Isopropylparaben |
| MMPs | Matrix metalloproteinases |
| MP | Methylparaben |
| PhP | Phenylparaben |
| PR | Progesterone receptor |
| PP | Propylparaben |
| TP53 | Tumor protein p53 |